Skip Navigation

Rheumatology 2007 46(10):1606-1611; doi:10.1093/rheumatology/kem179
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (3)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Huber, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Huber, A. M.
Related Collections
Right arrow Dermatomyositis and Polymyositis
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

The Cutaneous Assessment Tool: development and reliability in juvenile idiopathic inflammatory myopathy

A. M. Huber, E. M. Dugan1, P. A. Lachenbruch2, B. M. Feldman3, M. D. Perez4, L. S. Zemel5, C. B. Lindsley6, R. M. Rennebohm7, C. A. Wallace8, M. H. Passo9, A. M. Reed10, S. L. Bowyer11, S. H. Ballinger11, F. W. Miller12, L. G. Rider12 in cooperation with the Juvenile Dermatomyositis Disease Activity Collaborative Study Group*

IWK Health Centre and Dalhousie University, Halifax, Nova Scotia, Canada, 1Washington Hospital Center, Washington, DC, 2Center for Biologics Evaluation and Research, Food and Drug Administration, DHHS, Rockville, MD, USA, 3Hospital For Sick Children and University of Toronto, Toronto, Ontario, Canada, 4Texas Children's Hospital and Baylor College of Medicine, Houston, TX, 5Connecticut Children's Medical Center and University of Connecticut, Hartford, CT, 6University of Kansas, Kansas City, KS, 7Columbus Children's Hospital and Ohio State University, Columbus, OH, 8Children's Hospital and University of Washington, Seattle, WA, 9Children's Hospital and University of Cincinnati, Cincinnati, OH, USA, 10Mayo Clinic, Rochester, 11Riley Children's Hospital and Indiana University School of Medicine, Indianapolis and 12Environmental Autoimmunity Group, National Institute of Environmental Health Sciences, North Carolina.

Correspondence to: A. M. Huber, MD, Division of Pediatric Rheumatology, IWK Health Centre, 5850 University Avenue, Halifax, Nova Scotia, Canada B3K 6R8 E-mail: adam.huber{at}iwk.nshealth.ca


   Abstract

Objectives. Clinical care and therapeutic trials in idiopathic inflammatory myopathies (IIM) require accurate and consistent assessment of cutaneous involvement. The Cutaneous Assessment Tool (CAT) was designed to measure skin activity and damage in IIM. We describe the development and inter-rater reliability of the CAT, and the frequency of lesions endorsed in a large population of juvenile IIM patients.

Methods. The CAT includes 10 activity, 4 damage and 7 combined lesions. Thirty-two photographic slides depicting IIM skin lesions were assessed by 11 raters. One hundred and twenty-three children were assessed by 11 paediatric rheumatologists at 10 centres. Inter-rater reliability was assessed using simple agreements and intra-class correlation coefficients (ICC).

Results. Simple agreements in recognizing lesions as present or absent were generally high (0.5–1.0). ICCs for CAT lesions were moderate (0.4–0.75) in both slides and real patients. ICCs for the CAT activity and damage scores were 0.71 and 0.81, respectively. CAT activity scores ranged from 0 to 44 (median 7, potential range 0–96) and CAT damage scores ranged from 0 to 13 (median 1, potential range 0–22). The most common cutaneous lesions endorsed were periungual capillary loop changes (63%), Gottron's papules/sign (53%), heliotrope rash (49%) and malar/facial erythema (49%).

Conclusions. Total CAT activity and damage scores have moderate to good reliability. Assessors generally agree on the presence of a variety of cutaneous lesions. The CAT is a promising, semi-quantitative tool to comprehensively assess skin disease activity and damage in IIM.

KEY WORDS: Juvenile idiopathic inflammatory myopathy, Juvenile dermatomyositis, Skin disease, Cutaneous Assessment Tool, Assessment


*Contributors to this study are listed in the appendix.

Present address: P. A. Lachenbruch, Department of Public Health, Oregon State University, Corvallis, OR, USA.

Submitted 5 December 2006; revised version accepted 25 April 2007.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.